NASDAQ:NDRA ENDRA Life Sciences Q2 2026 Earnings Report $6.04 0.00 (0.00%) Closing price 09/25/2026 04:00 PM EasternExtended Trading$6.17 +0.13 (+2.20%) As of 09/25/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast ENDRA Life Sciences EPS ResultsActual EPS-$0.63Consensus EPS -$0.84Beat/MissBeat by +$0.21One Year Ago EPSN/AENDRA Life Sciences Revenue ResultsActual RevenueN/AExpected Revenue$0.10 millionBeat/MissN/AYoY Revenue GrowthN/AENDRA Life Sciences Announcement DetailsQuarterQ2 2026Date8/14/2026TimeBefore Market OpensConference Call DateFriday, August 14, 2026Conference Call Time7:00AM ETUpcoming EarningsENDRA Life Sciences' Q3 2026 earnings is estimated for Friday, November 13, 2026, based on past reporting schedules, with a conference call scheduled at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) ENDRA Life Sciences Earnings HeadlinesENDRA Shares Rise 12% As Q2 Loss Swings To Profit; Advances Noble Africa MergerSeptember 4, 2026 | rttnews.comENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business UpdateAugust 17, 2026 | finance.yahoo.com"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you make with it. Using the 4% rule as a benchmark, that balance could translate to about $100,000 in year one, adjusted upward for inflation each year after. But the 4% rule has potential downsides and may not fit every portfolio. A financial advisor can help size and structure a retirement budget around your income sources, taxes, and goals. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors.September 28 at 1:00 AM | SmartAsset (Ad)ASP Isotopes to Host Investor Meetings at Citi’s 2026 Natural Resources ConferenceAugust 5, 2026 | quiverquant.comQASP Isotopes Announces Capital Markets Day in London on September 8, 2026July 28, 2026 | quiverquant.comQENDRA Life Sciences (NDRA) Gets a Buy from AscendiantJuly 25, 2026 | theglobeandmail.comSee More ENDRA Life Sciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ENDRA Life Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ENDRA Life Sciences and other key companies, straight to your email. Email Address About ENDRA Life SciencesENDRA Life Sciences (NASDAQ:NDRA) is a medical technology company developing noninvasive imaging solutions for the assessment of tissue properties. Its technology is designed to expand the capabilities of conventional ultrasound systems by providing quantitative information that may support the detection and monitoring of disease. The company’s lead platform, TAEUS (Thermo-Acoustic Enhanced UltraSound), is being developed initially for the evaluation of liver fat associated with metabolic dysfunction-associated steatotic liver disease and related conditions. TAEUS is intended to work with existing ultrasound equipment, potentially offering clinicians a more accessible alternative to certain specialized imaging procedures. ENDRA Life Sciences is headquartered in Ann Arbor, Michigan, and its technology is under development and subject to regulatory review. The company’s primary focus is advancing TAEUS toward clinical use in liver imaging and exploring additional applications for its thermo-acoustic imaging approach.View ENDRA Life Sciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/21 - 09/252 Cybersecurity Stocks Breaking Out as AI Continues to Be a TailwindFertilizer Prices Keep Climbing: 3 Stocks Still Trading at a DiscountCostco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem5 Scary-Good Stocks With Strong October Catalysts and Breakout PotentialDarden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
